Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dejong, C.H.C."'
Autor:
Rosmalen, B.V. van, Furumaya, A., Klompenhouwer, A.J., Tushuizen, M.E., Braat, A.E., Reinten, R.J., Ligthart, M.A.P., Haring, M.P.D., Meijer, V.E. de, Voorthuizen, T. van, Takkenberg, R.B., Dejong, C.H.C., Man, R.A. de, IJzermans, J.N.M., Doukas, M., Gulik, T.M. van, Verheij, J., Dutch Benign Liver Tumor Grp, PALGA Grp
Publikováno v:
Liver International
Liver international, 41(10), 2474-2484. Wiley-Blackwell
Liver International, 41(10), 2474-2484. Wiley
Liver International, 41(10), 2474-2484. Wiley-Blackwell Publishing Ltd
Liver International, 41(10), 2474-2484. WILEY
Liver international, 41(10), 2474-2484. Wiley-Blackwell
Liver International, 41(10), 2474-2484. Wiley
Liver International, 41(10), 2474-2484. Wiley-Blackwell Publishing Ltd
Liver International, 41(10), 2474-2484. WILEY
BACKGROUND & AIMS: Hepatocellular adenomas (HCA) rarely occur in males, and if so, are frequently associated with malignant transformation. Guidelines are based on small numbers of patients and advise resection of HCA in male patients, irrespective o
Autor:
Beek, D.J. van, Nell, S., Vorselaars, W.M.C.M., Bonsing, B.A., Eijck, C.H.J. van, Goor, H. van, Dijkum, E.N.J. van, Dejong, C.H.C., Valk, G.D., Rinkes, I.M.B., Vriens, M.R., DutchMEN Study Grp DMSG
Publikováno v:
Annals of Surgical Oncology, 28, 8, pp. 4387-4399
Annals of Surgical Oncology, 28, 4387-4399
Annals of Surgical Oncology, 28(8), 4387-4399. Springer, Cham
Annals of Surgical Oncology, 28(8), 4387-4399. Springer New York
Annals of surgical oncology, 28(8), 4387-4399. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 28(8), 4387-4399. SPRINGER
Annals of Surgical Oncology, 28, 4387-4399
Annals of Surgical Oncology, 28(8), 4387-4399. Springer, Cham
Annals of Surgical Oncology, 28(8), 4387-4399. Springer New York
Annals of surgical oncology, 28(8), 4387-4399. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 28(8), 4387-4399. SPRINGER
Background Little is known about complications after major duodenopancreatic surgery for duodenopancreatic neuroendocrine tumors (dpNETs) in multiple endocrine neoplasia type 1 (MEN1). Therefore, the incidence and severity of complications after majo
Autor:
Latenstein, A.E.J., Roessel, S. van, Geest, L.G.M. van der, Bonsing, B.A., Dejong, C.H.C., Koerkamp, B.G., Hingh, I.H.J.T. de, Horns, M.Y.V., Klaase, J.M., Lemmens, V., Molenaar, I.Q., Steyerberg, W., Stommel, M.W.J., Busch, O.R., Eijck, C.H.J. van, Laarhoven, H.W.M. van, Wilmink, J.W., Besselink, M.G., Dutch Pancreatic Canc Grp
Publikováno v:
Annals of Surgical Oncology, 27, 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 2516-2524. SPRINGER
ISSUE=7;STARTPAGE=2516;ENDPAGE=2524;ISSN=1068-9265;TITLE=Annals of Surgical Oncology
Annals of Surgical Oncology, 27, 2516-2524. SPRINGER
Annals of Surgical Oncology, 27, 7, pp. 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer, Cham
Annals of surgical oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology, 27(7), 2516-2524. Springer New York
Annals of Surgical Oncology
Annals of Surgical Oncology, 2516-2524. SPRINGER
ISSUE=7;STARTPAGE=2516;ENDPAGE=2524;ISSN=1068-9265;TITLE=Annals of Surgical Oncology
Annals of Surgical Oncology, 27, 2516-2524. SPRINGER
Annals of Surgical Oncology, 27, 7, pp. 2516-2524
Annals of Surgical Oncology, 27(7), 2516-2524. Springer, Cham
Annals of surgical oncology, 27(7), 2516-2524. Springer New York
Background Conditional survival is the survival probability after already surviving a predefined time period. This may be informative during follow-up, especially when adjusted for tumor characteristics. Such prediction models for patients with resec
Autor:
Ruzzenente, A., Bagante, F., Olthof, P.B., Aldrighetti, L., Alikhanov, R., Cescon, M., Koerkamp, B.G., Jarnagin, W.R., Nadalin, S., Pratschke, J., Schmelzle, M., Sparrelid, E., Lang, H., Iacono, C., van Gulik, T.M., Guglielmi, A., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Campagnaro, T., Capobianco, I., Charco, R., de Reuver, P., de Savornin Lohman, E., Dejong, C.H.C., Efanov, M., Erdmann, J.I., Franken, L.C., Giovinazzo, G., Giglio, M.C., Gomez-Gavara, C., Heid, F., Ijzermans, J.N.M., Isaac, J., Jansson, H., Ligthart, M.A.P., Maithel, S.K., Malago, M., Malik, H.Z., Muiesan, P., Damink, S.W.M.O., Quinn, L.M., Ratti, F., Ravaioli, M., Rolinger, J., Schadde, E., Serenari, M., Troisi, R., van Laarhoven, S., van Vugt, J.L.A.
Publikováno v:
Annals of surgical oncology, 28, 460-461. Springer New York
Annals of Surgical Oncology, 28(SUPPL 3), 460-461. Springer New York
Annals of Surgical Oncology, 28(SUPPL 3), 460-461. Springer New York
Autor:
Huiskens, J., Bolhuis, K., Engelbrecht, M.R.W., Jong, K.P. de, Kazemier, G., Liem, M.S.L., Verhoef, C., Wilt, J.H.W. de, Punt, C.J.A., Gulik, T.M. van, Amerongen, M.J. van, Dejong, C.H.C., Gerhards, M.F., Grunhagen, D., Heijmen, L., Hermans, J.J., Keijser, A., Klaase, J.M., Lienden, K.P. van, Molenaar, Q.I., Patijn, G.A., Rijken, A.M., Ruers, T.M., Swijnenbur, R.J., Tinteren, H. van, Dutch Colorectal Canc Grp
Publikováno v:
Journal of the American College of Surgeons, 229(6), 523-532. Elsevier Inc.
Journal of The American College of Surgeons, 229(6), 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Inc.
Journal of the American College of Surgeons, 229, 6, pp. 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Science
Journal of the American College of Surgeons, 229, 523
Journal of the american college of surgeons, 229(6), 523-532.e2. ELSEVIER SCIENCE INC
Journal of The American College of Surgeons, 229(6), 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Inc.
Journal of the American College of Surgeons, 229, 6, pp. 523
Journal of the American College of Surgeons, 229(6), 523-532.e2. Elsevier Science
Journal of the American College of Surgeons, 229, 523
Journal of the american college of surgeons, 229(6), 523-532.e2. ELSEVIER SCIENCE INC
BACKGROUND: Decision making on optimal treatment strategy in patients with initially unresectable colorectal cancer liver metastases (CRLM) remains complex because uniform criteria for (un) resectability are lacking. This study reports on the feasibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ca01e90cd8794e41a294e3bd483faa2
https://hdl.handle.net/1887/121486
https://hdl.handle.net/1887/121486